CHIR-258

TKI-258 · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHIR-258, covering 2011-01-05 to 2011-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety of CHIR-258 (TKI258) in Advanced Solid Tumors [Phase 1]